Learner Objectives
Upon completion of this activity, you should be able to:
- Identify symptomology of cardiac amyloidosis including key clinical characteristics.
- Select appropriate testing and recognize findings suggestive of amyloidosis including biomarkers and echo.
Faculty
Amrut Ambardekar, MD, FACC
University of Colorado Health
Disclosures
Nothing to disclose.
Jan Griffin, MD, FACC
Medical University of South Carolina
Disclosures
Consultant Fees/Honoraria: AstraZeneca Pharmaceuticals, Bridgebio, Pfizer Inc
Research/Research Grants: Pfizer
Other: Bridgebio, Scripps
Planning Committee
Michelle Maya Kittleson, MD, FACC
California Heart Center
Disclosures
Nothing to disclose
Amrut Ambardekar, MD, FACC
University of Colorado Health
Disclosures
Nothing to disclose
Jan Griffin, MD, FACC
Medical University of South Carolina
Disclosures
Consultant Fees/Honoraria: Bridgebio, Pfizer Inc, AstraZeneca Pharmaceuticals
Research/Research Grants: Pfizer
Other: Scripps, Bridgebio